Steven Cohen's AARD Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 22,872 shares of Aardvark Therapeutics, Inc. (AARD) worth $131,743, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in AARD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 22,872 shares. Largest reduction occurred in Q1 2026, reducing 36,922 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Aardvark Therapeutics (AARD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aardvark Therapeutics (AARD) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +22,872 | New Buy | 22,872 | $5.76 |
| Q1 2026 | -36,922 | Sold Out | 0 | $0.00 |
| Q4 2025 | +36,922 | New Buy | 36,922 | $13.13 |
Steven Cohen's Aardvark Therapeutics Investment FAQs
Steven Cohen first purchased Aardvark Therapeutics, Inc. (AARD) in Q4 2025, acquiring 36,922 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Aardvark Therapeutics, Inc. (AARD) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Aardvark Therapeutics, Inc. (AARD) was in Q4 2025, adding 36,922 shares worth $484,602.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 22,872 shares of Aardvark Therapeutics, Inc. (AARD), valued at approximately $131,743.
As of the Q2 2026 filing, Aardvark Therapeutics, Inc. (AARD) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Aardvark Therapeutics, Inc. (AARD) was 36,922 shares, as reported at the end of Q4 2025.